Home/Filings/4/A/0000899243-18-022295
4/A//SEC Filing

Kapnick Scott 4/A

Accession 0000899243-18-022295

CIK 0001420565other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:35 PM ET

Size

5.5 KB

Accession

0000899243-18-022295

Insider Transaction Report

Form 4/AAmended
Period: 2017-07-05
Transactions
  • Purchase

    Common Stock

    2017-07-05$15.00/sh+66,666$999,99066,666 total(indirect: See Footnote)
Footnotes (2)
  • [F1]The amount of securities previously reported as beneficially owned by the Reporting Person inadvertently aggregated shares that the Reporting Person indirectly beneficially owned with shares that the Reporting Person directly beneficially owned following the transaction reported on the original Form 4. The correct number of shares that the Reporting Person indirectly beneficially owned following this transaction was 66,666 shares.
  • [F2]These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein.

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1
  • filerCIK 0001709654

Filing Metadata

Form type
4/A
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:35 PM ET
Size
5.5 KB